(Q26823562)

biomedical investigative technique

main subject

1 reference

19 September 2019

1 reference

17 November 2019

1 reference

20 November 2019

1 reference

15 August 2020

1 reference

13 November 2020

1 reference

17 December 2020

1

Lutz Heinemann

1 reference

Hootan Khatami

2

1 reference

Crossref

Ross McKinnon

series ordinal

3

1 reference

Crossref

Philip Home

series ordinal

4

1 reference

Crossref

language of work or name

1 reference

July 2015

1 reference

Diabetes technology & therapeutics

1 July 2015

7 references

19 September 2019

17 November 2019

20 November 2019

15 August 2020

13 November 2020

17 December 2020

22 August 2022

8 references

19 September 2019

17 November 2019

20 November 2019

15 August 2020

13 November 2020

17 December 2020

22 August 2022

17

1 reference

page(s)

510-26

1 reference

issue

7

1 reference

Creative Commons Attribution-NonCommercial

copyright license

7 references

19 September 2019

17 November 2019

20 November 2019

15 August 2020

13 November 2020

17 December 2020

22 August 2022

The emergence of biosimilar insulin preparations--a cause for concern?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

Insights from the Liraglutide Clinical Development Program--the Liraglutide Effect and Action in Diabetes (LEAD) studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

Epoetin-associated pure red cell aplasia: past, present, and future considerations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

The advent of biosimilar therapies in rheumatology—“O Brave New World”

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

Heterogeneity of commercial recombinant human growth hormone (r-hGH) preparations containing a thioether variant.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4504437

Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25789689

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25789689